Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Study of Intensive Chemotherapy With Autologous Peripheral Blood Stem Cell Support in Patients With Cisplatin Resistant Germ Cell Tumors

NCT00003852 is registered in ClinicalTrials.gov with UNICANCER as lead sponsor.

NCT NCT00003852
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00003852 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Study of Intensive Chemotherapy With Autologous Peripheral Blood Stem Cell Support in Patients With Cisplatin Resistant Germ Cell Tumors
Lead sponsor
UNICANCER
Phase
Phase 2
Overall status
Terminated
Start date
March 31, 1998
Completion date
March 31, 2000
Enrollment
45 (estimated)
Sites
18

Conditions

As the registry lists them; a condition with its own page is linked.

childhood germ cell tumor, extragonadal germ cell tumor, ovarian cancer, testicular germ cell tumor